Increased asymmetric dimethylarginine (ADMA) levels and insulin resistance in non-diabetic stage I kidney disease

被引：0
作者：
Yilmaz, Mahmut Ilker
Caglar, Kayser
Sonmez, Alper
Cakir, Erdinc
Kaya, Ayper
Acikel, Cengizhan
Eyileten, Tayfun
Yenicesu, Mujdat
Oguz, Yusuf
Bilgi, Cumhur
Oktenli, Cagatay
Vural, Abdulgaffar
Zoccali, Carmine
机构：
[1] Gulhane Sch Med, Ankara, Turkey
[2] CNR, IBIM, Reggio Di Calabria, Italy
[3] Inst Biomed Clin Epidemiol & Pathophysiol Renal D, Reggio Di Calabria, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
[41]   Smoking is associated with increased plasma asymmetric dimethylarginine (ADMA) levels in patients with type 2 diabetes mellitus [J].
Fard, A ;
Bryant, TA ;
Tuck, CH ;
Vest, JA ;
Sciacca, R ;
Di Tullio, MR ;
Chen, NT ;
Berglund, L ;
Ginsberg, HN ;
Homma, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :327A-327A
[42]   Asymmetric Dimethylarginine (ADMA) Regulation in Puromycin Aminonucleoside (PAN) Induced Chronic Kidney Disease (CKD) [J].
Cunningham, Mark W., Jr. ;
Chen, Gin-Fu ;
Tain, You-Lin ;
Sasser, Jennifer ;
Baylis, Chris .
FASEB JOURNAL, 2010, 24
[43]   Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD) [J].
Carmine Zoccali ;
Francesca Mallamaci ;
Giovanni Tripepi .
European Journal of Clinical Pharmacology, 2006, 62 :131-135
[44]   Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD) [J].
Zoccali, C ;
Mallamaci, F ;
Tripepi, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (Suppl 1) :131-135
[45]   Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance [J].
Zammit, Andrea R. ;
Katz, Mindy J. ;
Derby, Carol ;
Bitzer, Markus ;
Lipton, Richard B. .
PLOS ONE, 2015, 10 (10)
[46]   Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease [J].
Emrich, Insa E. ;
Zawada, Adam M. ;
Martens-Lobenhoffer, Jens ;
Fliser, Danilo ;
Wagenpfeil, Stefan ;
Heine, Gunnar H. ;
Bode-Boeger, Stefanie M. .
CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (03) :201-213
[47]   Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease [J].
Insa E. Emrich ;
Adam M. Zawada ;
Jens Martens-Lobenhoffer ;
Danilo Fliser ;
Stefan Wagenpfeil ;
Gunnar H. Heine ;
Stefanie M. Bode-Böger .
Clinical Research in Cardiology, 2018, 107 :201-213
[48]   Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? [J].
N. Chan ;
J. Chan .
Diabetologia, 2002, 45 :1609-1616
[49]   Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death [J].
Hedblad, B ;
Nilsson, P ;
Engstrom, G ;
Berglund, G ;
Janzon, L .
DIABETIC MEDICINE, 2002, 19 (06) :470-475
[50]   Insulin resistance and insulin secretion in non-diabetic acromegalic patients [J].
Coculescu, M. ;
Niculescu, D. ;
Lichiardopol, R. ;
Purice, M. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (05) :308-316
12345